-+ 0.00%
-+ 0.00%
-+ 0.00%
Novo Nordisk shares rose 2.5% after Cagrisema analysis showed early responders lost 25.4% of their weight.
Share
Listen to the news
Novo Nordisk shares rose 2.5% after Cagrisema analysis showed early responders lost 25.4% of their weight.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending